Cosmos Health Introduces High-Vote Series B Preferred, Elects Directors at Annual Meeting
COSM sits 71% above its 52-week low of $0.162.
Summary
Cosmos Health shareholders approved a new Series B Preferred Stock with 100 million votes and elected six directors at the 2026 annual meeting. The preferred shares carry no economic rights, serving solely as a voting control mechanism.
Key Events · Corporate Governance and Compliance · COSM
-
Series B Preferred Stock Approved
Shareholders approved 100,000 shares of Series B Preferred Stock with 1,000 votes per share (100 million total votes), no dividends, no conversion, and a $0.001 liquidation preference — a pure voting control mechanism.
-
Directors Elected
Six directors were elected: Grigorios Siokas, Demetrios G. Demetriades, John J. Hoidas, Dr. Anastasios Aslidis, Suhel Bhutawala, and Theodoros C. Karkantzos, each receiving over 79% affirmative votes.
-
Auditor Ratified
The appointment of the independent registered public accounting firm was ratified with 84.24% approval.
-
2026 Equity Omnibus Plan Approved
The 2026 Equity Omnibus Plan was approved with 79.58% of votes, enabling future equity-based compensation.
Analysis · COSM · Trade & Services
Shareholders of Cosmos Health approved a new Series B Preferred Stock carrying 100 million total votes — 1,000 votes per share — giving the board a powerful tool to control corporate outcomes without economic dilution. The 100,000 designated shares carry no dividends, no conversion rights, and a liquidation preference of just $0.001 per share, making them purely a voting mechanism. This move comes against a backdrop of a going-concern warning, a $100 million ATM program, and a recent $5 million buyback authorization — a governance step that could entrench management or facilitate a defensive strategy. The annual meeting also elected six directors and ratified the auditor, with all proposals passing by wide margins.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 30% of the 1963 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.14%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, COSM was trading at $0.28 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $17.4M. The 52-week trading range was $0.16 to $1.32. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.